Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients (vol 5, pg 495, 2010)

被引：0
|
作者：
Mazzoccoli, Gianluigi [1 ,2 ]
Notarsanto, Incoronata [1 ,2 ]
de Pinto, Gennaro Davide [1 ,2 ]
Dagostino, Mariangela Pia [1 ,2 ]
De Cata, Angelo [1 ,2 ]
D'Alessandro, Giuseppe [4 ]
Tarquini, Roberto [5 ]
Vendemiale, Gianluigi [3 ]
机构：
[1] Inst Sci, Dept Internal Med, I-71013 San Giovanni Rotondo, FG, Italy
[2] Reg Gen Hosp Casa Sollievo della Sofferenza, I-71013 San Giovanni Rotondo, FG, Italy
[3] Univ Foggia, Geriatr Unit, Dept Med Sci, Foggia, FG, Italy
[4] Univ Foggia, Dept Internal Med, Foggia, FG, Italy
[5] Univ Florence, Dept Internal Med, Florence, Italy
来源：
INTERNAL AND EMERGENCY MEDICINE | 2011年 / 6卷 / 01期
关键词：
D O I：
10.1007/s11739-010-0507-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [21] Anti-tumor necrosis factor-α therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis
    Uguz, Faruk
    Akman, Cemal
    Kucuksarac, Seher
    Tufekci, Osman
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 63 (01) : 50 - 55
  • [22] Laboratory changes on anti-tumor necrosis factor treatment in rheumatoid arthritis
    Ziolkowska, M
    Maslinski, W
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (03) : 267 - 273
  • [23] Should anti-tumor necrosis factor-α be the first therapy for rheumatoid vasculitis?
    Garcia-Porrua, C
    Gonzalez-Gay, MA
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 433 - 433
  • [24] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    [J]. ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [25] Effects of anti-tumor necrosis factor therapy on lipid profile in patients with rheumatoid arthritis
    Soubrier, Martin
    Jouanel, Pierre
    Mathieu, Sylvain
    Poujol, David
    Claus, Delphine
    Dubost, Jean Jacques
    Ristori, Jean Michel
    [J]. JOINT BONE SPINE, 2008, 75 (01) : 22 - 24
  • [26] The comparative effectiveness of methotrexate and anti-tumor necrosis factor therapy in psoriatic arthritis
    Christopher T. Ritchlin
    [J]. Current Rheumatology Reports, 2008, 10 (4) : 295 - 296
  • [27] Antiangiogenic effects of anti-tumor necrosis factor a therapy with infliximab in psoriatic arthritis
    Cañete, JD
    Pablos, JL
    Sanmartí, R
    Mallofré, C
    Marsal, S
    Maymó, J
    Gratacós, J
    Mezquita, J
    Mezquita, C
    Cid, MC
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (05): : 1636 - 1641
  • [28] Minimal Disease Activity and Anti-Tumor Necrosis Factor Therapy in Psoriatic Arthritis
    Haddad, Amir
    Thavaneswaran, Arane
    Ruiz-Arruza, Ioana
    Pellett, Fawnda
    Chandran, Vinod
    Cook, Richard J.
    Gladman, Dafna D.
    [J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (06) : 842 - 847
  • [29] Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis
    Kavanaugh, Arthur
    Tutuncu, Zuhre
    Catalan-Sanchez, Teresa
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (04) : 347 - 353
  • [30] Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-α therapy
    Kaur, PP
    Derk, CT
    Chatterji, M
    Dehoratius, RJ
    [J]. JOURNAL OF RHEUMATOLOGY, 2004, 31 (08) : 1663 - 1665
12345